A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/82466

Title:	A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio
Authors:	Chien, MH Lee, WJ Chang, YC Chang, WM Lai, TC Chan, DV Sharma, R Lin, YF Hsiao, M
Issue Date:	2017-06
Relation:	Molecular Cancer Therapeutics 16(6), 1102-1113
URI:	http://ir.sinica.edu.tw/handle/201000000A/82466
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1535-7163&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	https://www.ncbi.nlm.nih.gov/pubmed/28292939
Appears in Collections:	基因體研究中心

Show full item record

Last Week
1

Last month

checked on May 18, 2022

Check